Literature DB >> 32206594

Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas.

Juilee Rege1, Adina F Turcu2, William E Rainey1,2.   

Abstract

Primary aldosteronism (PA) is characterized by autonomous aldosterone production by renin-independent mechanisms and is most commonly sporadic. While 60-70% of sporadic PA can be attributed to bilateral hyperaldosteronism, the remaining 30-40% is caused by a unilateral aldosterone-producing adenoma (APA). Somatic mutations in or near the selectivity filter the KCNJ5 gene (encoding the potassium channel GIRK4) have been implicated in the pathogenesis of both sporadic and familial PA. Several studies using tumor tissue, peripheral and adrenal vein samples from PA patients have demonstrated that along with aldosterone, the hybrid steroids 18-hydroxycortisol (18OHF) and 18-oxocortisol (18oxoF) are a hallmark of APA harboring KCNJ5 mutations. Herein, we review the recent advances with respect to the molecular mechanisms underlying the pathogenesis of PA and the steroidogenic fingerprints of KCNJ5 mutations. In addition, we present an outlook toward the future of PA subtyping and diagnostic work-up utilizing steroid profiling. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  18-hydroxycortisol; 18-oxocortisol; Aldosterone-producing adenomas; CYP11B2; CYP17A1; KCNJ5; aldosterone

Year:  2020        PMID: 32206594      PMCID: PMC7082274          DOI: 10.21037/gs.2019.10.22

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  91 in total

1.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

2.  Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives.

Authors:  L Mosso; C E Gómez-Sánchez; M F Foecking; C Fardella
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

3.  Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.

Authors:  K C Loh; E S Koay; M C Khaw; S C Emmanuel; W F Young
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

4.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

Review 5.  Primary aldosteronism: renaissance of a syndrome.

Authors:  William F Young
Journal:  Clin Endocrinol (Oxf)       Date:  2007-05       Impact factor: 3.478

6.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.

Authors:  Namita G Hattangady; Shigehiro Karashima; Lucy Yuan; Daniela Ponce-Balbuena; José Jalife; Celso E Gomez-Sanchez; Richard J Auchus; William E Rainey; Tobias Else
Journal:  J Mol Endocrinol       Date:  2016-04-20       Impact factor: 5.098

8.  Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol.

Authors:  P Mulatero; K M Curnow; B Aupetit-Faisant; M Foekling; C Gomez-Sanchez; F Veglio; X Jeunemaitre; P Corvol; L Pascoe
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.

Authors:  Tracy Ann Williams; Silvia Monticone; Vivien R Schack; Julia Stindl; Jacopo Burrello; Fabrizio Buffolo; Laura Annaratone; Isabella Castellano; Felix Beuschlein; Martin Reincke; Barbara Lucatello; Vanessa Ronconi; Francesco Fallo; Giampaolo Bernini; Mauro Maccario; Gilberta Giacchetti; Franco Veglio; Richard Warth; Bente Vilsen; Paolo Mulatero
Journal:  Hypertension       Date:  2013-09-30       Impact factor: 10.190

10.  Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.

Authors:  Baojun Wang; Xintao Li; Xu Zhang; Xin Ma; Luyao Chen; Yu Zhang; Xiangjun Lyu; Yuzhe Tang; Qingbo Huang; Yu Gao; Yang Fan; Jinzhi Ouyang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

View more
  2 in total

1.  Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis.

Authors:  Yan Wang; Jun Cai
Journal:  Comput Intell Neurosci       Date:  2022-06-27

2.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.